
More blood clot cases following Johnson & Johnson COVID-19 vaccine reported
Fox News
Federal health officials have identified several additional cases of a rare but serious blood clot in people who received the J&J COVID-19 vaccine.
Shimabukuro reported 15 TTS cases amid a backdrop of nearly 8 million vaccinations, as of April 21. All of the reported cases were among women aged 18-59, with a median age of 37. Of the 15 total, 12 were identified as CVST with thrombocytopenia; the 11 other cases occurred in locations like the portal vein and pulmonary artery. Other potential cases under review include males. Officials excluded one female with a "complex and unique" case history. At least two patients experienced headaches starting more than six days post-vaccination, and other symptoms including chills and fever, while the later clinical course involved severe headaches and speech difficulty, among other symptoms.More Related News